Raymond Dwek
Director/Board Member chez UNITED THERAPEUTICS CORPORATION
Fortune : 402 010 $ au 31/03/2024
Profil
Raymond Allen Dwek is the founder of Oxford GlycoSciences Plc, which was founded in 1988.
He is currently an Independent Director at United Therapeutics Corp.
since 2002.
Mr. Dwek's former jobs include Chairman-Technology & Society at The Library of Congress, Director-Emeritus at Oxford Glycobiology Institute from 1988 to 2021, Professor & Head-Biochemistry Department at the University of Oxford from 1966 to 2009, and President at Institute of Biology from 2008 to 2010.
Mr. Dwek's education includes undergraduate and graduate degrees from the University of Oxford.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/04/2024 | 1 750 ( 0,00% ) | 402 010 $ | 31/03/2024 |
Postes actifs de Raymond Dwek
| Sociétés | Poste | Début |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | Director/Board Member | 01/01/2002 |
Anciens postes connus de Raymond Dwek
| Sociétés | Poste | Fin |
|---|---|---|
| Oxford Glycobiology Institute | Director/Board Member | 01/01/2021 |
| Institute of Biology | President | 01/01/2010 |
| University of Oxford | Corporate Officer/Principal | 01/01/2009 |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Director/Board Member | 01/01/2003 |
| The Library of Congress (District of Columbia) | Corporate Officer/Principal | - |
Formation de Raymond Dwek
| University of Oxford | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Entreprise privées | 3 |
|---|---|
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
| The Library of Congress (District of Columbia) | Government |
| Institute of Biology |
